Rasheed Ghany
Ranked 97 by citations to CLAD papers over ten years: 47 papers in the corpus, 360 citations. A bibliometric entry, not a quality judgement.
As of . Primary source: ORCID record.
Summary
Rasheed Ghany appears as an author of 47 papers (3.83 fractional) in the OpenAlex corpus of CLAD-related articles published from 2016-10-11 to 2026-10-10 (retrieved 2026-10-10). Those papers have been cited 360 times in total (whole counting), which places this author at rank 97 among 8,698 author profiles after merging duplicate OpenAlex profiles. 0 of the papers list the author in the first or last position. Affiliation: unknown (marked missing). Basis: unverified; OpenAlex lists "University Health Network" on the most recent corpus paper (2026). Not confirmed as current.. The corpus includes papers that only partly concern CLAD, and the counts describe publication and citation volume only. Linked papers are the author's most-cited papers matching CLAD terms in the title where possible.
Ranking method and caveats
Methodology for the researcher ranking
- Query: OpenAlex works of type article or review whose title or abstract contains "chronic lung allograft dysfunction" or "restrictive allograft syndrome", or "bronchiolitis obliterans" together with lung transplant terms. Retracted works and meeting-abstract supplements are removed.
- Window and date: works published 2016-10-11 to 2026-10-10; counts retrieved 2026-10-10 (2,461 works, 8,698 author profiles after merging).
- Counting: the rank is by total citations of the author's papers (whole counting). Fractional counts, first or last author papers and counts without the two 2019 ISHLT consensus papers are shown on each record.
- Identity: authors are identified by OpenAlex author identifier and ORCID. Duplicate profiles were merged by identical ORCID, or by compatible name plus shared institution. Only the top 30 entries were checked by hand.
- Rising researchers: a separate numbered list ordered by citations in the 5 years from 2021-10-11, for authors whose first paper in the corpus is dated 2019 or later and who have at least 5 papers in that window. It is a proxy, not a measure of career stage.
- Caveats: the corpus includes papers only partly about CLAD; consensus papers inflate some totals; recent papers are under-cited; author identifiers can be wrong; citations measure attention, not quality or clinical skill.
Details
- citation rank 10y
- 97 of 8,698 author profiles (top 100 listed)
- papers 10y
- 47
- fractional papers 10y
- 3.83
- citations 10y
- 360
- fractional citations 10y
- 27
- lead author papers 10y
- 0
- citations excluding two ishlt2019consensus papers
- 360
- rank excluding two ishlt2019consensus papers
- 86
- rising rank 5y
- 16 of 25
- ranking retrieved
- 2026-10-10
- orcid
- 0000-0002-2526-5107
- openalex author id
- A5057289348
- merged open alex profiles
- 2
- affiliation basis
- unverified; OpenAlex lists "University Health Network" on the most recent corpus paper (2026). Not confirmed as current.
Sources and links
- ORCID record (primary)
- OpenAlex author profile (ranking source)
- Most-cited CLAD paper in corpus: Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system (The Journal of Heart and Lung Transplantation, 2020); 77 citations; DOI 10.1016/j.healun.2020.04.012
- Most-cited CLAD paper in corpus: The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation (American Journal of Transplantation, 2020); 51 citations; DOI 10.1111/ajt.15561
- Most-cited CLAD paper in corpus: Significance of phenotype change after chronic lung allograft dysfunction onset (Transplant International, 2021); 12 citations; DOI 10.1111/tri.14157
- Most-cited CLAD paper in corpus: Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction (The Journal of Heart and Lung Transplantation, 2024); 10 citations; DOI 10.1016/j.healun.2024.01.002
- Most-cited CLAD paper in corpus: Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction (The Journal of Heart and Lung Transplantation, 2023); 10 citations; DOI 10.1016/j.healun.2023.03.009
Related
Links from this record
- author: Risk assessment of chronic lung allograft dysfunction phenotypes: Validation and proposed refinement of the 2019 International Society for Heart and Lung Transplantation classification system
- author: The impact of first untreated subclinical minimal acute rejection on risk for chronic lung allograft dysfunction or death after lung transplantation.
- author: Airway pepsinogen A4 identifies lung transplant recipients with microaspiration and predicts chronic lung allograft dysfunction
- author: Pulmonary epithelial markers in phenotypes of chronic lung allograft dysfunction
Known gaps in this record
- role or job title
- centre membership relation (not asserted)
- funding and conflicts of interest
- verified current affiliation
- only the top-30 entries were checked by hand for ID merges and splits
Information resource only. Not medical advice. Not a substitute for the care of the patient's transplant team.